NasdaqGM - Delayed Quote USD
Biodesix, Inc. (BDSX)
Tune into live earnings calls Now streaming directly on quote pages.
0.3716
+0.0238
+(6.84%)
At close: May 9 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 19.5M | 22.57M | 92.97M | 115.92M |
| Low Estimate | 18.4M | 22M | 92.03M | 110.02M |
| High Estimate | 20.3M | 23.7M | 94M | 120M |
| Year Ago Sales | 14.82M | 17.93M | 71.32M | 92.97M |
| Sales Growth (year/est) | 31.60% | 25.89% | 30.35% | 24.68% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.09 | -0.08 | -0.07 |
| EPS Actual | -0.14 | -0.08 | -0.07 | -0.06 |
| Difference | 0 | 0.01 | 0.01 | 0.01 |
| Surprise % | 2.32% | 13.04% | 7.89% | 10.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BDSX | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 4/29/2025 |
| Initiated | Scotiabank: Sector Outperform | 9/16/2024 |
| Initiated | Craig-Hallum: Buy | 7/26/2024 |
| Initiated | TD Cowen: Buy | 5/13/2024 |
| Initiated | Lake Street: Buy | 5/3/2024 |
| Reiterates | Canaccord Genuity: Buy to Buy | 3/4/2024 |
Related Tickers
VCYT Veracyte, Inc.
29.71
-4.81%
MDXH MDxHealth SA
1.8700
+3.31%
CSTL Castle Biosciences, Inc.
16.79
-2.47%
XGN Exagen Inc.
5.71
-7.31%
MYGN Myriad Genetics, Inc.
3.8900
-3.47%
AWHL Aspira Women's Health Inc.
0.0700
-12.50%
NDRA ENDRA Life Sciences Inc.
3.2600
-46.99%
PSNL Personalis, Inc.
5.04
-2.33%
EYWN.HA BioMerieux SA
117.30
+0.60%
EYWN.F bioMérieux S.A.
117.10
+1.12%